Takeda and Iambic ink $1.7 B deal to advance AI driven design of small molecules

Iambic, a US-based clinical-stage life science and technology company developing novel medicines using its artificial in...

February 11, 2026 | Wednesday | News
Zuellig Pharma acquires brands from Bayer to strengthen consumer healthcare portfolio

Singapore-headquartered Zuellig Pharma has acquired all rights, title, and interest in and to the Zam-Buk® and Vapex...

February 10, 2026 | Tuesday | News
Innovent inks $8.5 B deal with Eli Lilly for oncology and immunology based medicines

China-based Innovent Biologics, Inc. has announced a strategic collaboration with Eli Lilly and Company, in the US, to a...

February 10, 2026 | Tuesday | News
Sky Labs inks distribution agreement with Otsuka Pharma for 'CART BP pro' in Japan

South Korea-based startup Sky Labs Inc. has entered into an exclusive distribution agreement with Otsuka Pharmaceut...

February 6, 2026 | Friday | News
Richter and Fuji strengthen strategic collaboration in women healthcare segment

Budapest-based Gedeon Richter Plc. and Japan's Fuji Pharma Co. have announced the expansion and further strengthening of...

February 5, 2026 | Thursday | News
First Promega companion diagnostic receives China's NMPA approval

The National Medical Products Administration (NMPA) has approved the OncoMate® Microsatellite Instability (MSI) Dete...

February 5, 2026 | Thursday | News
Korea's Samsung Biologics collaborates with CEPI to strengthen outbreak-ready vaccine production

Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) and Samsung Biologics, a South Korea-based contract ...

February 4, 2026 | Wednesday | News
Amgen ends Rocatinlimab collaboration with Japan's Kyowa Kirin

Kyowa Kirin, a Japan-based global specialty pharmaceutical company, has announced the termination of the current rocatin...

February 4, 2026 | Wednesday | News
Korea's SK bioscience in-licenses RSV preventive mAb candidate from Gates Medical Research Institute

South Korea-based SK bioscience will advance a novel respiratory syncytial virus (RSV) monoclonal antibody (mAb) for glo...

February 3, 2026 | Tuesday | News
Australia's AdvanCell partners with 48Hour Discovery to develop novel radiotherapeutic for gastrointestinal cancer

Australia-based startup AdvanCell, a clinical-stage radiopharmaceutical company developing innovative targeted alpha the...

February 4, 2026 | Wednesday | News
Cambridge Health Group advances specialised neurological rehabilitation in UAE

Cambridge Health Group, the GCC's leading provider of post-acute care, has renewed its long-standing partnership with th...

February 2, 2026 | Monday | News
Frontage Labs strengthens early phase clinical capabilities across US and China

Frontage Laboratories, Inc., a global Contract Research, Development and Manufacturing Organization (CRDMO), has announc...

February 2, 2026 | Monday | News
DHL expands capabilities in Singapore to elevate life science & healthcare logistics

DHL Group has announced the expansion of its life sciences arm—DHL Health Logistics—with the development of ...

February 2, 2026 | Monday | News
Japan's Medical Corporation Nasukai forms strategic alliance with Daibi Medical Aesthetics

SBC Medical Group Holdings Incorporated, a global provider of comprehensive consulting and management services to medica...

February 2, 2026 | Monday | News
AstraZeneca inks billion-dollar deal with China's CSPC Pharma to expand weight management portfolio

AstraZeneca strengthens its weight management portfolio through a new strategic collaboration agreement with China-based...

February 3, 2026 | Tuesday | News
Vetter Pharma to build new manufacturing site in Germany

Vetter, one of the world's leading pharmaceutical service providers for the production of injectable drugs, has confirme...

January 30, 2026 | Friday | News
AstraZeneca plans $15 B investment in China to expand medicines manufacturing and R&D

AstraZeneca has announced $15 billion investment in China through 2030 to expand medicines manufacturing and R&D. Th...

January 30, 2026 | Friday | News
Baird Medical accelerates global commercial roadmap in partnership with Stonewood Key Capital in New Zealand

China-based Baird Medical Investment Holdings, a market leader in minimally invasive Microwave Ablation (MWA) technology...

January 29, 2026 | Thursday | News
WuXi Biologics and HanchorBio advances next-generation Bi- and Multi-functional fusion protein pipeline

WuXi Biologics, a global leading Contract Research, Development and Manufacturing Organization (CRDMO), and HanchorBio I...

January 29, 2026 | Thursday | News
Roche launches AI-enabled predictive CGM solution for diabetes management in Middle East

Roche Diagnostics Middle East presented a landmark launch event revealing Accu-Chek SmartGuide, a breakthrough Continuou...

January 28, 2026 | Wednesday | News
Korea's Hanmi Pharma secures export deal with Mexican partner Sanfer for GLP-1 obesity drug and more

Hanmi is accelerating its global market entry with efpeglenatide, Korea's first domestically developed GLP-1 c...

January 28, 2026 | Wednesday | News
Japan's Veritas In Silico partners with SpiroChem for discovery of next generation RNA drugs

Swiss firm SpiroChem AG and Japan-based Veritas In Silico Inc. have announced the signing of a Memorandum of Understandi...

January 28, 2026 | Wednesday | News
Boehringer Ingelheim, Simcere Pharma collaborate on €1,058 M IBD antibody deal

China-based Simcere Pharmaceutical Group and Germany-headquartered Boehringer Ingelheim have announced a license and col...

January 28, 2026 | Wednesday | News
PGxAI and Novo Genomics scale AI‑enabled pharmacogenomics across Saudi Arabia

Palo Alto‑based PGxAI, a leader in AI-powered pharmacogenomics, and Saudi Arabia’s Novo Genomics&...

January 23, 2026 | Friday | News
Japan's Otsuka and Towa form strategic partnership in pharmaceutical manufacturing

Japan-based companies Otsuka Pharmaceutical Co. and Towa Pharmaceutical Co. have entered into an agreement to establish ...

January 27, 2026 | Tuesday | News